For an excellent blog post about predatory publishing or deceptive publishing, check out what Rick Anderson shares (The Scholarly Kitchen, Aug 17, 2015). This is an issue that continues to plague the scholarly communication landscape with some publishers truly behaving like wolves in sheep’s clothing. The most important thing we can do for our researchers, whether they are just starting their publishing careers or are seasoned authors, is to highlight and make them aware of unscrupulous publishers. Continue reading
Author Archives: Donna
Special Event, Marking an Anniversary, and MSK Staff in the News
An assortment of news items worth sharing….
- On September 26, Memorial Sloan Kettering will be co-hosting a conference on Mesothelioma. The general public as well as health care professionals are welcome. Registration and conference details can be found here.
- From the MSK On Cancer Blog, Sloan Kettering Institute marks its seventy year anniversary.
- A study published recently in JAMA (Sep 3, 2015) linked exposure to Agent Orange to an increased risk of developing a blood disorder which is a precursor to (but does not always develop into) the blood cancer multiple myeleoma. Dr. Ola Landgren, a hematologic oncologist at MSK is the study lead.
- Cancer treatment and age – more factors to consider? Dr. Stuart Lichtman, Medical Oncologist from MSK shares his comments.
- Dr. Mark Souweidane, has been named chair of the editorial board for The Journal of Neurosurgery: Pediatrics.
New Partnership, Blog Post, and News About MSK Staff
A selection of news items about MSK and staff!
- Lehigh Valley Health Network of Salisbury joined the MSK Cancer Alliance. Dr. Craig Thompson, President and CEO of MSK is quoted.
- From the MSK Blog, Neurologist Gavril Pasternak’s lab has developed an opioid derivative that works as well as traditional opioids for pain management.
- Lightpoint Medical, a device company specializing in imaging technologies announced that it has received an R01 grant of $2.6 million from the US National Cancer Institute. The funding will support clinical trials of Lightpoint’s EnLight™ molecular imaging technology in lymph node cancer and a range of gynecologic cancers at MSK.
- The Cancer Research Institute, a nonprofit organization dedicated to supporting the discovery and development of immunotherapies for all forms of cancer will be honoring three scientists for their contributions at an upcoming awards dinner scheduled for Wednesday, September 17, 2015, in New York city. One of the researchers to receive the 2015 William B. Coley Award for Distinguished Research in Basic Immunology is Alexander Rudensky, Ph.D., Chairman of the Immunology Program and Director of the Ludwig Center at MSK. Continue reading